RhumbLine Advisers
SRTA

RhumbLine Advisers’s Strata Critical Medical Inc SRTA Stock Holding History

RhumbLine Advisers’s Portfolio SRTA Stock Details SRTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$694K Buy
131,710
+4,462
+4% +$23.5K ﹤0.01% 2544
2026
Q1 		$532K Buy
127,248
+1,019
+0.8% +$4.91K ﹤0.01% 2576
2025
Q4 		$607K Sell
126,229
-3,335
-3% -$16.1K ﹤0.01% 2556
2025
Q3 		$656K Sell
129,564
-5,155
-4% -$22.8K ﹤0.01% 2509
2025
Q2 		$543K Buy
134,719
+52,533
+64% +$171K ﹤0.01% 2639
2025
Q1 		$224K Sell
82,186
-58,593
-42% -$210K ﹤0.01% 3053
2024
Q4 		$598K Buy
140,779
+7,037
+5% +$26.8K ﹤0.01% 2556
2024
Q3 		$393K Buy
133,742
+47,210
+55% +$150K ﹤0.01% 2870
2024
Q2 		$301K Sell
86,532
-2,599
-3% -$8.67K ﹤0.01% 3004
2024
Q1 		$254K Sell
89,131
-6,761
-7% -$20.9K ﹤0.01% 3057
2023
Q4 		$338K Buy
95,892
+10,065
+12% +$28.9K ﹤0.01% 2906
2023
Q3 		$222K Sell
85,827
-7,047
-8% -$24.8K ﹤0.01% 3099
2023
Q2 		$366K Buy
92,874
+8,832
+11% +$28K ﹤0.01% 2887
2023
Q1 		$284K Buy
84,042
+587
+0.7% +$2.39K ﹤0.01% 2632
2022
Q4 		$299K Buy
83,455
+1,992
+2% +$8.51K ﹤0.01% 2679
2022
Q3 		$328K Sell
81,463
-3,302
-4% -$17K ﹤0.01% 2690
2022
Q2 		$378K Buy
+84,765
New +$612K ﹤0.01% 2631

Other funds holding SRTA

TP
Third Point New York $4.68B AUM 37.3% 1-Year Est. Return
NRCM
Northern Right Capital Management Darien, Connecticut $337M AUM 63.03% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
PLC
Pillsbury Lake Capital San Francisco, California $366M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

RhumbLine Advisers's SRTA Position: Q2 2026 in Review

RhumbLine Advisers increased its Strata Critical Medical Inc (SRTA) stake by 3.5% in Q2 2026, buying an estimated $23.5K and bringing the position to 131,710 shares worth $694K. The position accounts for ﹤0.01% of the portfolio, ranked #2544.

RhumbLine Advisers first reported a position in SRTA in Q2 2022 and has held it in 17 quarters since. 139 funds tracked by Wall St. Rank hold SRTA as of Q2 2026.

  • RhumbLine Advisers held 131,710 shares of Strata Critical Medical Inc worth $694K as of Q2 2026.
  • RhumbLine Advisers bought 4,462 Strata Critical Medical Inc shares in Q2 2026, an estimated $23.5K.
  • Strata Critical Medical Inc made up ﹤0.01% of RhumbLine Advisers's portfolio in Q2 2026, its #2544 holding.
  • RhumbLine Advisers first reported a position in Strata Critical Medical Inc in Q2 2022 and has held it in 17 quarters since.
  • 139 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q2 2026.

Based on RhumbLine Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.